Implanted Neurostimulator Monthly Battery & Lead Integrity Log

ContextA lead that delivers therapy smoothly should produce paresthesia that is consistent and predictable. Any sensation that feels like a sudden jolt, electric shock, muscle contraction, or sharp zap — particularly one that startles you or interrupts activity — is a clinical symptom, not a normal variation. Log the date, the body region affected, the intensity (1–10), and whether it was isolated or repetitive. Painful, violent stimulation jolts that persist or worsen may indicate a conductor fracture creating arcing current, a loose connector pin, or contact of the lead with an unintended tissue structure. Do not increase your amplitude to compensate — contact your device clinic before the next scheduled visit.

ContextStand up, sit down, bend forward, turn your torso, and note whether your stimulation sensation changes in character, intensity, or coverage area during these movements. Stimulation that surges when you flex your spine, fades when you reach overhead, or shifts sides when you lie down on your right versus left is a classic positional symptom of lead migration or a micro-fracture that opens and closes with mechanical tension. This is sometimes called 'positional stimulation.' Log which specific movements trigger the change and whether the effect is immediate or gradual. This positional history is among the most diagnostically useful information your clinician receives when evaluating a lead on fluoroscopy.

ContextSome patient programmers are equipped to display basic impedance alerts — typically an icon, color code, or text message indicating a lead-related fault. If you see any such notification, do not dismiss it or assume it will resolve. Screenshot or photograph the alert on your programmer screen, note the date, and contact your device clinic. Unlike battery warnings, impedance faults do not follow a predictable timeline — they can appear suddenly after a trauma, a fall, or even spontaneously from internal conductor fatigue. Log which contact or channel is flagged if the programmer provides that detail; this helps your clinician prepare the right diagnostic approach before your visit.

ContextYour therapy coverage map — the areas of your body where you feel stimulation — should remain consistent between programming sessions unless your clinician intentionally changes parameters. New paresthesia appearing in areas not previously covered (e.g., now feeling stimulation in the foot when previously it was only in the lower back, or feeling it on the left side when it was strictly right-sided) often indicates the lead tip has shifted position. Sketch or describe the new coverage area in your log. If the new area includes your chest, face, groin, or any area that concerns you, contact your clinic promptly — some lead migrations can reach unintended neural structures.

ContextIf the paresthesia or relief you experience at, say, 2.8mA this month required only 2.4mA last month — and no one has changed your programming — you may be compensating for lead migration, impedance rise, or tolerance. Log your current working amplitude alongside last month's entry and note whether the difference was self-adjusted (you turned it up yourself) or clinician-adjusted. Self-escalating amplitude over multiple months that still does not restore prior relief is a pattern that warrants earlier contact with your device team rather than continuing to push settings toward the upper limit of your program.

ContextUse a consistent scale: 0 = no relief at all (same as no stimulation), 10 = complete relief with no residual symptoms. For best accuracy, rate each day briefly in a note app or calendar and calculate the monthly average, rather than relying on an end-of-month recollection, which is heavily biased toward the most recent week. A consistent monthly average is one of the most powerful tools for demonstrating long-term therapy benefit to your insurer and justifying device replacement at end of life. If your average drops more than 2 points compared to the prior 3-month average without any parameter change or new medical issue, flag it for clinical review.

ContextAsk your clinician for a printed parameter summary at each visit, or access it through your patient programmer if your system allows. Log: amplitude (in mA or V), frequency (in Hz), pulse width (in microseconds), the electrode configuration (which contacts are active and their polarity), and whether you are using a tonic, burst, high-frequency, or other waveform. These numbers matter because any unexplained change in your therapy experience is only interpretable if you know what baseline you were operating at. Many patients adjust amplitude daily within a programmed range — record your typical working amplitude, not just the upper limit.

ContextYour device should only turn off when you deliberately shut it off or when it passes through a strong magnetic field (such as some MRI environments or anti-theft gates). An unplanned shutoff — where stimulation simply stops while you are going about your day — should never be dismissed as a fluke. Log the date, time, what you were doing, and whether you were near any electrical equipment. Spontaneous resets (where the device reboots and returns to default settings) are a separate event and are particularly important to report, as they can indicate a firmware anomaly or hardware issue that the manufacturer may need to investigate.

ContextDefine 'adequate' in advance: for example, 'pain at 4/10 or below and able to complete normal daily activities.' Then count how many of the month's days met that threshold and how many did not. A device delivering adequate coverage on 27 of 30 days is performing very differently than one achieving it on 14 of 30 days — yet both might receive the same 'it works pretty well' verbal summary at a clinic visit. This count is especially valuable when you are considering a programming revision, a device upgrade, or a switch to a new therapy modality. It transforms a subjective impression into a trackable metric.

ContextNew symptoms in a neurostimulator patient have two possible sources: the underlying condition progressing, or the device contributing. Log all new or worsened symptoms regardless of your assumption about their origin — headache, new back pain location, arm weakness, mood change, sleep disruption, or any other change. Include the approximate date of onset. Your clinician needs this to distinguish between disease progression (which may require a medication change or imaging) and device-related side effects (which may require reprogramming). Do not self-diagnose the cause; the log's job is documentation, not interpretation.

ContextIn good lighting, examine the skin over your implanted pulse generator. The skin should be its normal color — no pink, red, or purple discoloration. Press gently around (not directly on) the device: the tissue should feel soft and not significantly warmer than surrounding skin. Mild firmness directly over the IPG is normal — it is the body's natural capsule forming around the device. However, any combination of warmth, redness, and tenderness that is new or increasing is the classic triad of early pocket infection. Infection rates for neurostimulators are approximately 3–5% over the device's lifetime; caught early, most resolve with oral antibiotics. Caught late, they require surgical revision. Do not wait for a fever before reporting this triad.

ContextLook at the skin directly over your IPG and over the connector block (where the leads attach to the device). Skin erosion — where the hardware appears to be pushing through or visibly bulging — is a serious complication requiring surgical intervention. It can develop slowly over weeks as the tissue thins, or rapidly after weight loss, trauma, or a poorly positioned implant. Early erosion appears as a pale, shiny, almost translucent patch of skin over the hardware. If you can see the outline of the device edge or feel a sharp ridge close to the skin surface, photograph it and contact your device clinic the same day. Left unaddressed, erosion leads to device exposure and mandatory removal.

ContextUsing light fingertip pressure, trace the path from your IPG pocket upward toward where the leads enter the spine (or the target nerve for peripheral devices). Feel for any lumps, gaps, or kinks that were not previously there — these may indicate a connector issue, a seroma, or lead coiling under the skin. Also note if pressing on a specific spot along the path reproduces your stimulation sensation or causes pain: this can indicate a lead that has become tethered to the fascia or a micro-fracture site where local pressure disrupts the circuit. A new tender spot along a previously painless path is a meaningful finding to include in your log.

ContextSome discomfort directly over an implant is expected in the first 6–12 weeks post-surgery as the pocket heals and the capsule forms. Beyond that window, persistent or newly developing pain at the implant site — especially pain that is worse when lying on that side, worsens with pressure, or is accompanied by a pulling sensation — may indicate pocket migration (the IPG shifting position), seroma formation, or hardware-related irritation of adjacent tissue. Log the character of the pain (aching, sharp, burning), when it is worse, and whether it is constant or intermittent. This is separate from your therapy-related pain score and should be documented independently.

ContextYour original surgical incisions — whether at the pocket site, at the spine for percutaneous leads, or at the paddle lead incision — should be fully closed, flat, and non-tender at one month post-surgery. At any time after that, new drainage (clear, yellow, or bloody), a wound that appears to be reopening, crusting, or an unusual odor emanating from the area must be logged and reported immediately. Even years after surgery, a dormant bacterial biofilm on implant hardware can reactivate after an immune challenge (illness, dental procedure, skin infection nearby) and present as late-onset wound breakdown. This is rare but requires prompt evaluation — do not treat it with over-the-counter antibiotic cream without clinician guidance.

ContextCreate a simple list of every medical encounter this month: dental work, diagnostic imaging (X-ray, CT, ultrasound), physical therapy modalities, minor surgeries, or procedures using electrocautery or laser. For each, note the date, the procedure, the provider, and whether your neurostimulator was disclosed and turned off beforehand. This log serves two purposes: first, some procedures (particularly RF-based or microwave-based diathermy) can damage your device or leads even when used far from the implant site. Second, your device clinic uses this history to interpret unexpected changes in your interrogation data — if your impedance jumped in March, knowing you had a surgical procedure in March provides a crucial context clue.

ContextMRI is one of the highest-risk interactions for implanted neurostimulators. Many modern devices are labeled 'MRI-conditional,' meaning MRI is permitted only under specific conditions: defined scanner field strength (typically 1.5T), specific body regions excluded, device in a designated MRI mode, and leads fully implanted (not externalized). Log the scan date, the scanner's field strength, the body region scanned, and whether your device programmer was used to set the MRI-safe mode before scanning. If any of these conditions were skipped, disclose this to your device clinic regardless of whether you experienced any immediate symptoms — thermal injury to lead tips or reprogramming of the device can occur without pain.

ContextThese three modalities — all common in physical therapy, sports medicine, and surgical suites — use electromagnetic energy that can couple with lead conductors and cause local tissue heating along the entire lead path, not just at the treatment site. Therapeutic ultrasound and shortwave diathermy are absolutely contraindicated in patients with implanted neurostimulators, regardless of how far the treatment site is from the hardware. Electrocautery used during surgery requires specific precautions (bipolar preferred, grounding pad placement matters). If any of these were used this month, note the exact modality, the treating provider, and whether your device was disclosed. Retroactive logging of this information is important even if no immediate adverse effect was noticed.

ContextAirport body scanners, handheld security wands, and large anti-theft gate systems can temporarily inhibit or activate some neurostimulators, causing unexpected stimulation changes or brief shutoffs. Walk-through metal detectors specifically can trigger magnetic reed switches in some older devices. Log any instance where you passed through such equipment, including whether you declared your device and requested a manual pat-down (which is your right and is recommended). Also note any workplace exposures: industrial welding equipment, large electric motors, arc furnaces, and high-voltage power lines all produce fields capable of interfering with device function. The log note does not need to be lengthy — date, location, and a description of any perceived sensation change is sufficient.

ContextOver-the-counter TENS units, EMS (electrical muscle stimulation) pads, and similar devices introduce exogenous electrical currents into the body's tissues. When used on or near the torso, neck, or near any part of the implanted system, they can theoretically interact with the implanted hardware or produce unintended current pathways through lead conductors. Many device manufacturers specifically advise against using TENS on the same body region as the implant, or recommend avoiding TENS altogether. Log any use, the device type, the body region, and whether your clinician has been informed of this practice. Heated blankets and standard electric heating pads over the implant site have also been associated with skin injury in patients where device proximity reduces normal pain perception.

ContextBefore filing this month's log, pull out last month's entry and place them side by side. Look for any discrepancy that does not have an obvious explanation: a battery drop larger than previous months, a parameter that has changed when you did not have a clinic visit, a new symptom that appeared the same week as a new electromagnetic exposure. This comparison step is the core of longitudinal monitoring — individual data points have limited meaning; trends and discontinuities are where the clinical signal lives. Flag any discrepancy with a brief note in the 'items requiring review' section at the bottom of the log, even if you are uncertain of its significance.

ContextWhen your clinician interrogates your device — using their manufacturer programmer — they generate a printed or electronic summary showing battery voltage, lead impedances by contact, cumulative therapy hours, and the full parameter set. This report contains objective data that your patient programmer cannot display. Attach a physical copy to your monthly log binder, or note the date of the visit and file the report in a labeled folder. Over multiple years, these interrogation reports form a medical-grade longitudinal dataset of your device's electrical performance. They are also critical evidence for insurance prior authorization when seeking IPG replacement — retain every report for the full lifespan of your device.

ContextLog the date, the clinician's name, and what was changed: new amplitude range, new frequency, new active contacts, a new program added, a waveform type change, or a therapy mode adjustment. If you were not given a written summary, ask for one before leaving the appointment — most clinics are willing to print a parameter sheet on request. This record matters because any change in your therapy experience in the weeks following a programming visit has a known baseline to compare against. It also documents that you are actively under clinical management, which supports continuity of care if you ever change providers or need an emergency consultation.

ContextWrite the date, clinic name, and contact number directly in this month's log. Standard follow-up intervals vary by device type and patient stability: many programs recommend 3–6 month visits for stable patients, with annual or semi-annual full interrogations. If more than 12 months have passed since your last formal device interrogation — not just a programming tweak, but a full battery and impedance report — contact your clinic to schedule one regardless of whether you have any symptoms. Silent impedance changes and battery depletion can occur without obvious patient-reported symptoms until they are well advanced.

ContextCreate a dedicated section at the end of your monthly log labeled 'Items requiring earlier review.' Scan every entry you have made this month and ask: does this finding fit within the expected range I have established over prior months, or is it a new, unexplained, or worsening finding? Anything that is new, unexplained, or directionally worsening belongs in this section with a brief note. This flag list becomes your opening statement at your next clinic visit, ensuring nothing gets forgotten in the time pressure of a clinical appointment. If the flagged item seems urgent — not something to delay until a routine visit — use it as the basis for calling your clinic for an earlier appointment.